Mucin structure. The structure and heterogeneity of respiratory mucus glycoproteins
- PMID: 1892325
- DOI: 10.1164/ajrccm/144.3_pt_2.S4
Mucin structure. The structure and heterogeneity of respiratory mucus glycoproteins
Abstract
Respiratory mucus glycoproteins purified from both "normal" respiratory secretions and sputa of patients with a variety of hypersecretory conditions are high Mr linear molecules adopting a random coil configuration in solution. Studies on their polydispersity show them to have an Mr in the range 3 to 32 x 10(6) and a distribution of length from 200 nm to beyond 10 microns. These macromolecules are fragmented by reduction of intermolecular disulfide bonds into subunits, with Mr approximately 2 x 10(6) and length from 200 to 600 nm. Reduction not only cleaves the mucin molecule but opens, presumably by breaking intramolecular disulfide bonds, cryptic "naked" protein regions. Trypsin digestion of subunits yields high Mr glycopeptides (Mr, 300 to 500,000), presumably by cleavage of the peptide core within the unfolded "naked" protein domains. Respiratory mucus glycoproteins from infected sputum samples are usually heterogeneous in CsCl density gradients, in contrast to those from "normal" tracheobronchial secretions. The former are characterized by the presence of a number of different mucin species, and the basis for the separation of these mucins appears to be the variable presence of sialic acid and sulfate moieties in the oligosaccharide clusters. This heterogeneity may reflect a difference in cellular origin of the mucins and also may be clinically significant.
Similar articles
-
Structure and macromolecular properties of cervical mucus glycoproteins.Symp Soc Exp Biol. 1989;43:289-316. Symp Soc Exp Biol. 1989. PMID: 2701481 Review.
-
Mucus glycoproteins from cystic fibrotic sputum. Macromolecular properties and structural 'architecture'.Biochem J. 1991 Jun 15;276 ( Pt 3)(Pt 3):667-75. doi: 10.1042/bj2760667. Biochem J. 1991. PMID: 2064605 Free PMC article.
-
Mucus glycoproteins from 'normal' human tracheobronchial secretion.Biochem J. 1990 Jan 1;265(1):179-86. doi: 10.1042/bj2650179. Biochem J. 1990. PMID: 2302164 Free PMC article.
-
The structure of tracheobronchial mucins from cystic fibrosis and control patients.J Biol Chem. 1992 Feb 15;267(5):3160-7. J Biol Chem. 1992. PMID: 1737770
-
Gel-forming mucins. Notions from in vitro studies.Histol Histopathol. 2007 Apr;22(4):455-64. doi: 10.14670/HH-22.455. Histol Histopathol. 2007. PMID: 17290356 Review.
Cited by
-
Sialomucin complex in the rat respiratory tract: a model for its role in epithelial protection.Biochem J. 1998 Mar 1;330 ( Pt 2)(Pt 2):737-44. doi: 10.1042/bj3300737. Biochem J. 1998. PMID: 9480884 Free PMC article.
-
Mucus Structure, Viscoelastic Properties, and Composition in Chronic Respiratory Diseases.Int J Mol Sci. 2024 Feb 5;25(3):1933. doi: 10.3390/ijms25031933. Int J Mol Sci. 2024. PMID: 38339210 Free PMC article. Review.
-
Airway mucus: From production to secretion.Am J Respir Cell Mol Biol. 2006 May;34(5):527-36. doi: 10.1165/rcmb.2005-0436SF. Epub 2006 Jan 13. Am J Respir Cell Mol Biol. 2006. PMID: 16415249 Free PMC article. Review.
-
Binding of Haemophilus influenzae to purified mucins from the human respiratory tract.Infect Immun. 1995 Jul;63(7):2485-92. doi: 10.1128/iai.63.7.2485-2492.1995. Infect Immun. 1995. PMID: 7790060 Free PMC article.
-
Airway mucus in pulmonary diseases: Muco-adhesive and muco-penetrating particles to overcome the airway mucus barriers.Int J Pharm. 2023 Mar 5;634:122661. doi: 10.1016/j.ijpharm.2023.122661. Epub 2023 Feb 1. Int J Pharm. 2023. PMID: 36736964 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources